Psychedelics-Assisted Treatments
Metapsy Allows you to Analyze Living Databases on Psychedelic Treatments
Maintained by the SYPRES
Collaboration
Renewed interest in psychedelics as treatments for mental disorders and symptoms has produced a rapidly growing body of research across public and private spheres over the last decade.
However, there are substantial challenges in synthesizing evidence from available data to inform both clinical decision-making and policy.
We are establishing a series of living systematic reviews (LSRs) as a means to navigate the dynamic and rapidly burgeoning evidence base.
SYPRES adheres to the principles of open science, transparency, and data accessibility.
By providing a comprehensive and continuously updated repository of meta-analyses, we aim to support researchers, clinicians, policymakers, and patients in making informed decisions about the therapeutic potential of psychedelics.
Every element of SYPRES is open and reproducible – including database searches, data extraction, data processing, and all analyses.
SYPRES thus combines open data and open code to maximize reproducibility and enhance confidence. Please visit the SYPRES website for living updates on our analyses and open-source code.
This effort is supported by the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks and Pediatric Anesthesia Safety Initiative (ACTTION/PASI) public-private partnership with the U.S. FDA.
